INS and Hypoglycemia: The variables that most explained the heterogeneity were bolus insulin (26%) and definition of hypo (14%) for general hypoglycemia, cross-over design (23%) and intervention brand (13%) for nocturnal hypoglycemia, and Jadad score (16%) for A1C.